Basis of Presentation and Summary of Significant Accounting Policies, Net Loss Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	603,991	855,129
Stock Options [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	521,726	772,864
Common Stock Warrants [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	80,000	80,000
Restricted Stock Units [Member]
Antidilutive Securities Excluded from Computation of Net Loss Per Share [Abstract]
Potential common stock equivalents (in shares)	2,265	2,265